35 million to Gvm for research, technology and digitalization of the healthcare sector
© Agenzia Nova – Reproduction reserved
The European Investment Bank (EIB) has announced a €35 million financing to support the research, development and innovation activities of GVM, one of the leading Italian hospital groups. The financing is supported by InvestEu, the European Union investment programme, of which the EIB Group is the main implementing partner. The EIB intervention aims to make care more accessible and personalised, to digitise and automate the services offered to patients and to improve operational efficiency. In detail, the financing will enable GVM to develop medical devices in the cardiopulmonary and extracorporeal life support fields, to conduct clinical and translational research for cardiovascular and metabolic diseases and to enhance the digital infrastructure in all the group’s main healthcare facilities in Italy. In addition, with reference to the subsidiary Eurosets, the construction of a new state-of-the-art production plant is planned, as an extension of the existing site in Medolla, in the province of Modena. The projects will be completed by 2027.
“This funding supports research and development of new medical technologies, helping to create a more resilient, efficient and modern healthcare system,” he said. Jasmine Vigliotti, Vice President of the EIB. “Investing in innovation and digitalisation in the healthcare sector is essential to improve operational efficiency and ensure a rapid and adequate response to future challenges,” he added. “The group is constantly oriented towards increasingly increasing the quality and volumes of the offer for the benefit of our patients and users through significant investments in structural expansions, technology, digitalisation, research and new organisational solutions,” underlined Ettore Sansavini, President of GVM. “Thanks to the now historic relationship with the EIB, which we are deeply honoured by, we will be able to implement various development projects along multiple lines, in order to fuel the production of new devices, research and the care services offered, in a dynamic and rapidly evolving context, with important opportunities to be seized,” he concluded.
Read also other news on Nova News
Click here and receive updates on WhatsApp
Follow us on the social channels of Nova News on Twitter, LinkedIn, Instagram, Telegram
© Agenzia Nova – Reproduction reserved
link
